Company family
Rowa: medicine shortages
As of 2 Nov 2026, 5 Rowa products have a reported shortage across 1 countries, covering 4 medicines.
Products short5rank #313 of 464
Medicines4active ingredients
Countries1/16
New in 90 days2-2 vs market pace
Typical duration4 monthsmedian so far
Manufacturing20%demand-driven 60%
Where
Which therapeutic classes
Why, compared with all companies
Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.
When its current shortages began
Against its peers
Breadth vs depth
Further right: more products short. Higher: more different medicines affected.
Medicines short
| Medicine | Where this company is short | Products | Earliest start | Main reason | Short anywhere |
|---|---|---|---|---|---|
| Ezetimibe | 1 | 14 Sep 2026 | Increased demand | 9/16 | |
| Mefenamic Acid | 1 | 8 Jun 2026 | Quality problem or recall | 4/16 | |
| Midazolam | 1 | 7 Sep 2026 | Manufacturing problem | 7/16 | |
| Tramadol and Paracetamol | 1 | 13 Jul 2026 | Increased demand | 5/16 |
Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.